Skip to main content

Iodinated Liposomes as Contrast Agents

  • Chapter
Nanoparticles in Biomedical Imaging

Part of the book series: Fundamental Biomedical Technologies ((FBMT,volume 102))

Abstract

The use of liposomal contrast agents for computed tomography (CT) imaging applications is considered. The properties of the various liposome types as well as methods for their preparation are discussed. Specific challenges for the preparation and use of CT contrast-carrying liposomes are outlined. Available experience on the use of CT liposomes for liver and spleen imaging in preclinical animal models and humans is reviewed. The use of surface-modified and conventional liposomes for CT blood-pool imaging is discussed in light of the published animal data. Finally, new trends in the use of CT liposomes are considered based on the limited data available to date.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allen, T.M., 1994. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv Drug Delivery Rev 13, 285–309.

    Article  CAS  Google Scholar 

  • Benita, S., Poly, P.A., Puisieux, F., Delattre, J., 1984. Radiopaque liposomes: effect of formulation conditions on encapsulation efficiency. J Pharm Sci 73, 1751–1755.

    Article  PubMed  CAS  Google Scholar 

  • Bodganov, A.A., Weissleder, R., Brady, T.J., 1995. Long-circulating blood pool imaging agents. Adv Drug Delivery Rev 16, 335–348.

    Article  Google Scholar 

  • Caride, V.J., Sostman, H.D., Twickler, J., et al., 1982. Brominated radiopaque liposomes: contrast agent for computed tomography of liver and spleen: a preliminary report. Invest Radiol 17, 381–385.

    Article  PubMed  CAS  Google Scholar 

  • Cheng, K.T., Seltzer, S.E., Adams, D.F., Blau, M., 1987. The production and evaluation of contrast-carrying liposomes made with an automatic high-pressure system. Invest Radiol 22, 47–55.

    Article  PubMed  CAS  Google Scholar 

  • Daeniker, F., 1980. Neues Leberkontrastmittel und Verfahren zu dessen Herstellung. DE 29 35 195 A1.

    Google Scholar 

  • Desser, T.S., Rubin, D.L., Muller, H., et al., 1999. Blood pool and liver enhancement in CT with liposomal iodixanol: comparison with iohexol. Acad Radiol 6, 176–183.

    Article  PubMed  CAS  Google Scholar 

  • Dick, A., Adam, G., Tacke, J., et al., 1996. Computed tomography of experimental liver abscesses using a new liposomal contrast agent. Invest Radiol 31, 194–203.

    Article  PubMed  CAS  Google Scholar 

  • Erdogan, S., Özer, A.Y., Ercan, M.T., et al., 1998. Biodistribution and computed tomography studies on iopromide liposomes. STP Pharma Sciences 8, 133–137.

    CAS  Google Scholar 

  • Fouillet, X., Tournier, H., Khan, H., et al., 1995. Enhancement of computed tomography liver contrast using iomeprol-containing liposomes and detection of small liver tumors in rats. Acad Radiol 2, 576–583.

    Article  PubMed  CAS  Google Scholar 

  • Goebel, F.D., Goldstein, D., Goos, M., et al., 1996. Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi’s sarcoma. Br J Cancer 73, 989–994.

    PubMed  CAS  Google Scholar 

  • Havron, A., Seltzer, S.E., Davis, M.A., Shulkin, P., 1981. Radiopaque Liposomes: a promising new contrast material for computed tomography of the spleen. Radiology 140, 507–511.

    PubMed  CAS  Google Scholar 

  • Henze, A., Freise, J., Magerstedt, P., Majewski, A., 1989. Radio-opaque liposomes for the improved visualization of focal liver disease by computed tomography. Comput Med Imaging Graph 13, 455–462.

    Article  PubMed  CAS  Google Scholar 

  • Jendrasiak, G.L., Frey, G.D., Heim, R.C., 1985. Liposomes as carriers of iodolipid radio-contrast agents for CT scanning of the liver. Invest Radiol 20, 995–1002.

    Article  PubMed  CAS  Google Scholar 

  • Johnston, S.L., Lee, M.W., Hawthorne, M.F., 2003. Development of cell-surface protein targeted CT and MR contrast agents. Suppl Appl Radiol 70–77.

    Google Scholar 

  • Kao, C., Hoffmann, E.A., Beck, K.C., et al., 2003. Long-residence-time nano-scale liposomal iohexol for x-ray-based blood pool imaging. Acad Radiol 10, 475–483.

    Article  PubMed  Google Scholar 

  • Katayama, H., Spinazzi, A., Fouillet, X., et al., 2001. Iomeprol: current and future profile of a radiocontrast agent. Invest Radiol 36, 87–96.

    Article  PubMed  CAS  Google Scholar 

  • Krause, W., Klopp, R., Leike, J., et al., 1995. Liposomes in diagnostic imaging– comparison of modalities–in-vivo visualization of liposomes. J Liposome Res 5, 1–26.

    Article  CAS  Google Scholar 

  • Krause, W., Leike, J., Sachse, A., Wagner, S., et al., 1991. Preclinical characterization of iopromide-carrying liposomes. Invest Radiol 26, S172–S174.

    PubMed  CAS  Google Scholar 

  • Lasic, D.D., 1993. Liposomes: from physics to applications, Elsevier Science Publishers B.V., 63 ff.

    Google Scholar 

  • Leander, P., 1996. A new liposomal contrast medium for CT of the liver–an imaging study in a rabbit tumour model. Acta Radiol 37, 63–68.

    Article  PubMed  CAS  Google Scholar 

  • Leander, P., Höglund, Kloster, Y., Borseth, A., 1998. New liposomal liver-specific contrast agent for CT: first human phase i clinical trial assessing efficacy and safety. Acad Radiol 5,Suppl 1 S6–S8.

    Article  PubMed  Google Scholar 

  • Leander, P., Höglund, P., Borseth, A., et al., 2001. A new liposomal liver-specific contrast agent for CT: first human phase-I clinical trial assessing efficacy and safety. Eur Radiol 11, 698–704.

    Article  PubMed  CAS  Google Scholar 

  • Leike, J.U., Sachse, A., Rupp, K., 2001. Characterization of continuously extruded iopromide-carrying liposomes for computed tomography blood-pool imaging. Invest Radiol 6, 303–308.

    Article  Google Scholar 

  • Lopez-Berestein, G., Kasi, L., Rosenblum, M.G., et al., 1984. Clinical Pharmacology of 99m Tc-labeled Liposomes in Patients with Cancer. Cancer Research 44, 375–378.

    PubMed  CAS  Google Scholar 

  • Martin, F.J., 1990. Pharmaceutical manufacturing of liposomes, in Praveen T. (ed.), Specialized drug delivery systems, Marcel Dekker, Inc., 267–316.

    Google Scholar 

  • Muschik, P., Sachse, A., Leike, J., et al., 1995. Lipid dependent cardio-haemodynamic tolerability of liposomes in rats. J Liposome Res 5, 933–953.

    Article  Google Scholar 

  • New RRC, 1990. Preparation of liposomes, in New RRC (ed.), Liposomes a practical approach, Oxford University Press, 33–104.

    Google Scholar 

  • Olson, F., Hunt, C.A., Szoka, F.C., et al., 1979. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim Biophys Acta 557, 9–23.

    Article  PubMed  CAS  Google Scholar 

  • Payne, N.I., Whitehouse, G.H., 1987. Delineation of the spleen by a combination of proliposomes with water-soluble contrast media: an experimental study using computed tomography. Br J Radiol 60, 535–541.

    Article  PubMed  CAS  Google Scholar 

  • Petersein, J., Franke, B., Fouillet, X., Hamm, B., 1999. Evaluation of liposomal contrast agents for liver CT in healthy rabbits. Invest Radiol 34, 401–409.

    Article  PubMed  CAS  Google Scholar 

  • Poste, G., 1983. Liposome targeting in vivo: problems and opportunities. Biol Cell 47, 19–38.

    CAS  Google Scholar 

  • Rozenberg, O.A., Loshakova, L.V., Mikhailova, N.Y., et al., 1993. Triombrast in liposomes for liver and spleen imaging: The first phase of the clinical trials. Centr Okt N5, 35–37 (Russian paper).

    Google Scholar 

  • Rummeny, E.J., Berning, W., Fuest, M., et al., 1999. Evaluation of a new blood pool agent for CT-angiography. Eur Radiol 9, S24.

    Google Scholar 

  • Rummeny, E.J., Berning, W., Fuest, M., et al., 2002. New RES-specific contrast agents for CT. Acad Radiol 9,Suppl 1, S185–S190.

    Article  Google Scholar 

  • Ryan, P.J., Davis, M.A., DeGaeta, L.R., et al., 1984. Liposomes loaded with contrast material for image enhancement in computed tomography–work in progress. Radiology 152, 759–762.

    PubMed  CAS  Google Scholar 

  • Ryan, P.J., Davis, M.A., Melchior, D.L., 1983. The preparation and characterization of liposomes containing X-ray contrast agents. Biochim Biophys Acta 756, 106–110.

    PubMed  CAS  Google Scholar 

  • Sachse, A., 1998. Large-scale production of liposomes by continuous high pressure extrusion. In: Mueller, R.H., Benita, S., Boehm, B. (eds.), Emulsions and nanosuspensions for the formulation of poorly soluble drugs, medpharm Scientific Publishers, Stuttgart, 257–265.

    Google Scholar 

  • Sachse, A., Leike, J.U., Röβling, G., et al., 1993. Preparation and evaluation of lyophilized iopromide-carrying liposomes for liver tumor detection. Invest Radiol 28, 838–844.

    PubMed  CAS  Google Scholar 

  • Sachse, A., Leike, J.U., Schneider, T., et al., 1997. Biodistribution and computed tomography blood-pool imaging properties of polyethylene glycol-coated iopromide-carrying liposomes. Invest Radiol 32, 44–50.

    Article  PubMed  CAS  Google Scholar 

  • Schmiedl, U.P., Krause, W., Leike, J., et al., 1995. Liver contrast enhancement in primates using iopromide liposomes. Acad Radiol 2, 967–972.

    Article  PubMed  CAS  Google Scholar 

  • Schmiedl, U.P., Krause, W., Leike, J., Sachse, A., 1999. CT blood pool enhancement in primates with iopromide-carrying liposomes containing soy phosphatidyl glycerol. Acad Radiol 6, 164–169.

    Article  PubMed  CAS  Google Scholar 

  • Schneider, T., Sachse, A., Röβling, G., Brandl, M., 1995. Generation of contrast-carrying liposomes of defined size with a new continuous high pressure extrusion method. Int Journ Pharm 117, 1–12.

    Article  CAS  Google Scholar 

  • Seltzer, S.E., 1988a. Liposomes in diagnostic imaging. In: Gregoriadis, G. (ed.) Liposomes as drug carriers. Chichester, NY: John Wiley & Sons 509–525.

    Google Scholar 

  • Seltzer, S.E., 1988b. Contrast-carrying liposomes, current status. Invest Radiol 23,Suppl 1, S122–S125.

    Google Scholar 

  • Seltzer, S.E., Blau, M., Herman, L.W., et al., 1995. Contrast material-carrying liposomes: biodistribution, clearance, and imaging characteristics. Radiology 194, 775–781.

    PubMed  CAS  Google Scholar 

  • Seltzer, S.E., Davis, M.A., Adams, D.F., et al., 1984a. Liposomes carrying diatrizoate: characterization of biophysical properties and imaging applications. Invest Radiol 19, 142–151.

    Article  CAS  Google Scholar 

  • Seltzer, S.E., Gregoriadis, G., Dick, R., 1988. Evaluation of the dehydration-rehydration method for production of contrast-carrying liposomes. Invest Radiol 23, 131–138.

    Article  PubMed  CAS  Google Scholar 

  • Seltzer, S.E., Shulkin, P.M., Adams, D.F., et al., 1984b. Usefulness of liposomes carrying iosefamate for CT opacification of liver and spleen. AJR 143, 575–579.

    CAS  Google Scholar 

  • Senior, J.H., 1987. Fate and behaviour of liposomes in vivo: A review of controlling factors. CRC Crit Rev Therap Drug Carrier Syst 3, 123–193.

    CAS  Google Scholar 

  • Spinazzi, A., Ceriati, S., Pianezzola, P., et al., 2000. Safety and pharmacokinetics of a new liposomal liver-specific contrast agent for CT–results of clinical testing in nonpatient volunteers. Invest Radiol 35 1–7.

    Google Scholar 

  • Szoka, F., Papahadjopoulos, D., 1978. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Nat Acad Sci USA 75, 4194–4198.

    Article  PubMed  CAS  Google Scholar 

  • Tilcock, C., 1994. Liposomal blood pool agents for nuclear medicine and magnetic resonance imaging. J Liposome Res 4, 909–936.

    Article  CAS  Google Scholar 

  • Tilcock, C., 1999. Delivery of contrast agents for magnetic resonance imaging, computed tomography, nuclear medicine and ultrasound. Adv Drug Delivery Rev 37, 33–51.

    Article  CAS  Google Scholar 

  • Torchilin, V.P., 2005. Recent advances with liposomes as pharmaceutical carriers. Nature Reviews 4, 145–160.

    Article  PubMed  CAS  Google Scholar 

  • Torchilin, V.P., Trubetskoy, V.S., 1995. In vivo visualizing of organs and tissues with liposomes. J Liposome Res 5, 795–812.

    Article  CAS  Google Scholar 

  • Zalutsky, M.R., Noska, M.A., Seltzer, S.E., 1987. Characterization of liposomes containing iodine-125-labeled radiographic contrast agents. Invest Radiol 22, 141–147.

    Article  PubMed  CAS  Google Scholar 

  • Zerbin, E.A., Davidenkova, E.F., Chanson, K.P., et al., 1985. Ein neues Verfahren zur Kontrastdarstellung von Leber und Milz unter Anwendung wasserlöslicher Röntgenkontrastmittel in Liposomen. Radiol Diagn 26, 285–292. (German paper)

    Google Scholar 

  • Zheng, J., Perkins, G., Kirilova, A., et al., 2006. Multimodal contrast agent for combined computed tomography and magnetic resonance imaging applications. Invest Radiol 41, 339–348.

    Article  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Sachse, A. (2008). Iodinated Liposomes as Contrast Agents. In: Bulte, J.W., Modo, M.M. (eds) Nanoparticles in Biomedical Imaging. Fundamental Biomedical Technologies, vol 102. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72027-2_18

Download citation

Publish with us

Policies and ethics